Gina Gambetta
Off-label use and pricing among concerns amid booming market for drugs made by pharma firms such as Novo Nordisk.
Corporates, investors and commodity countries split on risks and benefits of proposed postponement.
Respondents call on Competition Bureau to address uncertainties, as well as avoid unintended consequences, in upcoming guidance.
Most CA100+ investors were tight-lipped on reports that the energy giant has scrapped its 2030 oil and gas reduction target.
The latest ESG movers and shakers: CEO of the Church Commissioners for England steps down; DWS names head of sustainability risk.
Network details plans for policy work in seven markets, including Australia and Canada.
Dutch investor wary of high-level proposals and lack of transparency around demands, but cautions ability to file is a 'fundamental right'.
Consumer goods firm facing plastics and regenerative agriculture proposals at AGM this week.
One year on from the launch of the TNFD framework, financial institutions reflect on progress made in early reporting and outline key challenges faced.
New greenwashing rules have shortfalls but move to drop claims from website is an ‘overreaction’, say investors.